Literature DB >> 16798672

Persistent infection of RAW264.7 macrophages with the DA strain of Theiler's murine encephalomyelitis virus: An in vitro model to study viral persistence.

Stephane Steurbaut1, Bart Rombaut, Raf Vrijsen.   

Abstract

Theiler's murine encephalomyelitis virus (TMEV) is a member of the Picornaviridae family and causes a virus strain dependent pathology in the central nervous system of mice. The GDVII strain induces an acute and mostly fatal encephalomyelitis. In the few mice that survive, the virus is cleared by the immune system. In contrast, infection with the DA strain leads to a persistent infection, marked by inflammation and demyelination that resembles multiple sclerosis. In the DA-induced disease, macrophages play a crucial role because they contribute to demyelination by the secretion of toxic mediators. Moreover, they represent the main viral reservoir, hereby also underlining their essential role in TMEV persistence. The mechanism of this persistence is not yet understood and tools to investigate it directly, without the complexity imposed by experimental animals, are largely missing. By studying TMEV infection of RAW264.7 macrophages, we found that the DA strain establishes a persistent infection in these cells, in contrast to the neurovirulent GDVII strain. Whereas the GDVII strain was cleared within 4 to 5 days post infection, DA virions were still present after 1 year of cell cultivation. This persistently DA-infected macrophage cell line, which we have called DRAW, provides a model to investigate the interactions between the cellular and viral factors influencing persistence and to screen for anti-TMEV agents.

Entities:  

Mesh:

Year:  2006        PMID: 16798672     DOI: 10.1080/13550280600714120

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  29 in total

Review 1.  Theiler's virus infection of the mouse, or: of the importance of studying animal models.

Authors:  Michel Brahic
Journal:  Virology       Date:  2002-09-15       Impact factor: 3.616

2.  The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins.

Authors:  Sophie Delhaye; Vincent van Pesch; Thomas Michiels
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 3.  The genetics of the persistent infection and demyelinating disease caused by Theiler's virus.

Authors:  Michel Brahic; Jean-François Bureau; Thomas Michiels
Journal:  Annu Rev Microbiol       Date:  2005       Impact factor: 15.500

Review 4.  Theiler's virus persistence in the central nervous system of mice is associated with continuous viral replication and a difference in outcome of infection of infiltrating macrophages versus oligodendrocytes.

Authors:  Howard L Lipton; A S Manoj Kumar; Mark Trottier
Journal:  Virus Res       Date:  2005-08       Impact factor: 3.303

5.  A single amino acid change determines persistence of a chimeric Theiler's virus.

Authors:  N Jarousse; R A Grant; J M Hogle; L Zhang; A Senkowski; R P Roos; T Michiels; M Brahic; A McAllister
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

6.  The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production.

Authors:  V van Pesch; O van Eyll; T Michiels
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 7.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

8.  A protein critical for a Theiler's virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence.

Authors:  G D Ghadge; L Ma; S Sato; J Kim; R P Roos
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Low-neurovirulence Theiler's viruses use sialic acid moieties on N-linked oligosaccharide structures for attachment.

Authors:  Ankur H Shah; Howard L Lipton
Journal:  Virology       Date:  2002-12-20       Impact factor: 3.616

10.  SPONTANEOUS ENCEPHALOMYELITIS OF MICE, A NEW VIRUS DISEASE.

Authors:  M Theiler
Journal:  J Exp Med       Date:  1937-04-30       Impact factor: 14.307

View more
  5 in total

1.  Cytokine/chemokine profile in J774 macrophage cells persistently infected with DA strain of Theiler's murine encephalomyelitis virus (TMEV).

Authors:  Toshiki Himeda; Takako Okuwa; Yasushi Muraki; Yoshiro Ohara
Journal:  J Neurovirol       Date:  2010-05       Impact factor: 2.643

2.  Theiler's virus strain-dependent induction of innate immune responses in RAW264.7 macrophages and its influence on viral clearance versus viral persistence.

Authors:  Stephane Steurbaut; Bart Rombaut; Raf Vrijsen
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

Review 3.  Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis.

Authors:  Ikuo Tsunoda; Robert S Fujinami
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-06       Impact factor: 4.147

4.  IRF3 helps control acute TMEV infection through IL-6 expression but contributes to acute hippocampus damage following TMEV infection.

Authors:  Tyler C Moore; Liz Cody; Phyllis M Kumm; Deborah M Brown; Thomas M Petro
Journal:  Virus Res       Date:  2013-10-17       Impact factor: 3.303

5.  Modulation of viral replication in macrophages persistently infected with the DA strain of Theiler's murine encephalomyelitis virus.

Authors:  Stephane Steurbaut; Ellen Merckx; Bart Rombaut; Raf Vrijsen
Journal:  Virol J       Date:  2008-08-04       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.